Skip to content
Search

Latest Stories

Community Pharmacy England seeks pharmacy owners view ahead of its committee meeting

The Community Pharmacy England Committee has adopted a new approach to engagement with sector by inviting all pharmacy owners to share their views on pharmacy’s finances, pressures and capacity ahead of its meeting in July.

It has sought views of pharmacists via short poll by Sunday (2 July) and will have a discussion on the poll results at the meeting before reporting back to the sector afterwards.


The key focus for July Committee Meeting will be to make most of £645m for the community pharmacy sector, and also on the ongoing work to make the wider case for more investment in the sector.

This new way of working follows association's rebrand on 30th May which signalled the start of its new approach to engagement to help them to build stronger relationships with pharmacy owners.

The association hopes this new approach will help them better engage with members and listen to pharmacy’s views better.

Survey for July’s Meeting

To help make the feedback process easier for busy pharmacy owners, we have developed a series of polls to gauge your thoughts on topical issues. The short survey of mostly multiple-choice questions should take around 10 minutes to complete.

For the July meeting, we are keen to hear your views on your pharmacy’s finances, pressures and capacity. In particular, we want to know how your business is coping financially, the impact the current economic situation is having on the care you can provide patients, your capacity to offer advanced services, and what changes (other than funding) would make your life easier.

Beyond this, there is also space to add additional feedback should you have more to share, and a section where you can tell us what other topics we should collect pharmacy owners’ thoughts on.

Note, this survey is for community pharmacy owners and head office representatives only.

Janet Morrison, Chief Executive of Community Pharmacy England, said: “We are now in the middle of critical negotiations to make sure that community pharmacies benefit as much as possible from the £645m investment that was promised to the sector as part of the Government’s Primary Care Access Plan. We are also continuing to highlight the immense pressures on the sector and to press for further support and investment in the sector.

"This critical work will clearly be the focus of our upcoming Committee Meeting, but we have also ringfenced time at the Committee to reflect on what we are hearing from all of you, as the pharmacy owners we represent. As the voice of community pharmacy, we want to collaborate even more with our members across the sector. Our new pre-Committee Meeting polling offers the chance for all pharmacy owners to tell us about their reflections, primary concerns and challenges, as well as their ideas for future polling.

"The results of this poll will help us to listen to and to better represent your views, and the data we gather will also help us to get our key messages across to Ministers, officials and other policymakers. There is a real commitment from everyone here to shift the ways in which we engage with you, and in time we hope these surveys will become a really valuable tool in delivering your thoughts directly to our Committee, and beyond.

I’m conscious that this is yet another survey, but the more we hear from you the more powerfully we can represent your views to Government, so I hope you will be able to find ten minutes to complete the survey. You can also use it to let us know if you would rather we engaged with you in other ways in the future, or to flag other key issues – whatever you are able to share, we’ll be listening.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less